Media & Events

Keep up-to-date on the latest media coverage and events for IceCure Medical.

Filter by:

News

IceCure Medical Delivers Conference Call Investor Update Sept 2019

IceCure CEO, Eyal Shamir and CFO, Ronen Tsimerman update on IceCure progress in investor conference call, Sept 2019. Listen to the full conference call here.

Read More >

News

IceCure Medical Forges Landmark Strategic Deal with Global Medical Company, Terumo Corporation

The exclusive distribution agreement, supported by Terumo’s strong commitment, will accelerate commercialization of its ProSense™ cryoablation system to treat breast cancer tumors in Japan and Singapore, pending regulatory approval. Read more

Read More >

News

IceCure Receives Israeli AMAR Approval for Use of its Freezing Technology in Specific Indications, Following an Earlier General Approval

The AMAR approval allows for freezing of benign and malignant tumors including breast, lungs, bones, liver, lymphatic tissue, lymph nodes and endocrine glands. This achievement comes hot on the back of the company receiving a Class 3 CPT code from

Read More >

Events

ICECURE TO CONDUCT HANDS-ON CRYOABLATION DEVICE TRAINING AT CIRSE 2019, SEPT 10, 12:30-14:00

Register now for our hands-on-device training at the Cardiovascular and Interventional Radiological Society of Europe annual conference on September 10th at 12:30-14:00. Come and learn more about how our next generation liquid nitrogen (LN2) cryoablation system, ProSense™, works to advance

Read More >

Events

ICECURE SUPPORTS THE FIRST-EVER BREAST CANCER LIQUID NITROGEN CRYOABLATION CONFERENCE, SEPT 20-21, 2019, KAMEDA MEDICAL CENTER

Led by leading expert, Professor Eisuke Fukuma, we are proud to support the first-ever breast cancer liquid nitrogen (LN2) cryoablation conference at Kameda Medical Center. Join this must-attend event to hear the latest clinical insights and results from leading doctors

Read More >